Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

Diffusing Capacity is an Independent Predictor of Outcomes in Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease.

Balasubramanian A, Kolb TM, Damico RL, Hassoun PM, McCormack MC, Mathai SC.

Chest. 2020 Mar 14. pii: S0012-3692(20)30445-1. doi: 10.1016/j.chest.2020.02.047. [Epub ahead of print]

PMID:
32184109
2.

Progress in Understanding, Diagnosing, and Managing Cardiac Complications of Systemic Sclerosis.

Hung G, Mercurio V, Hsu S, Mathai SC, Shah AA, Mukherjee M.

Curr Rheumatol Rep. 2019 Dec 7;21(12):68. doi: 10.1007/s11926-019-0867-0. Review.

PMID:
31813082
3.

Serum uric acid as a marker of disease risk, severity, and survival in systemic sclerosis-related pulmonary arterial hypertension.

Simpson CE, Damico RL, Hummers L, Khair RM, Kolb TM, Hassoun PM, Mathai SC.

Pulm Circ. 2019 Jul 29;9(3):2045894019859477. doi: 10.1177/2045894019859477. eCollection 2019 Jul-Sep.

4.

Oxygen use in chronic heart failure to relieve breathlessness: A systematic review.

Asano R, Mathai SC, Macdonald PS, Newton PJ, Currow DC, Phillips J, Yeung WF, Davidson PM.

Heart Fail Rev. 2020 Mar;25(2):195-205. doi: 10.1007/s10741-019-09814-0. Review.

PMID:
31222538
5.

A crossroads between the heart and lungs: air pollution and pulmonary hypertension.

McCormack MC, Mathai SC.

Eur Respir J. 2019 May 30;53(5). pii: 1900654. doi: 10.1183/13993003.00654-2019. Print 2019 May. No abstract available.

PMID:
31147423
6.

Validation of the REVEAL Prognostic Equation and Risk Score Calculator in Incident Systemic Sclerosis-Associated Pulmonary Arterial Hypertension.

Mullin CJ, Khair RM, Damico RL, Kolb TM, Hummers LK, Hassoun PM, Steen VD, Mathai SC; PHAROS Investigators.

Arthritis Rheumatol. 2019 Oct;71(10):1691-1700. doi: 10.1002/art.40918. Epub 2019 Aug 26.

PMID:
31066998
7.

Pulmonary Embolism.

Essien EO, Rali P, Mathai SC.

Med Clin North Am. 2019 May;103(3):549-564. doi: 10.1016/j.mcna.2018.12.013. Review.

PMID:
30955521
8.

Identifying Patients with Pulmonary Arterial Hypertension Using Administrative Claims Algorithms.

Mathai SC, Hemnes AR, Manaker S, Anguiano RH, Dean BB, Saundankar V, Classi P, Nelsen AC, Gordon K, Ventetuolo CE.

Ann Am Thorac Soc. 2019 Jul;16(7):797-806. doi: 10.1513/AnnalsATS.201810-672CME.

9.

Ventricular mass as a prognostic imaging biomarker in incident pulmonary arterial hypertension.

Simpson CE, Damico RL, Kolb TM, Mathai SC, Khair RM, Sato T, Bourji K, Tedford RJ, Zimmerman SL, Hassoun PM.

Eur Respir J. 2019 Apr 4;53(4). pii: 1802067. doi: 10.1183/13993003.02067-2018. Print 2019 Apr. No abstract available.

PMID:
30705128
10.

Disconnect between Fibrotic Response and Right Ventricular Dysfunction.

Crnkovic S, Egemnazarov B, Damico R, Marsh LM, Nagy BM, Douschan P, Atsina K, Kolb TM, Mathai SC, Hooper JE, Ghanim B, Klepetko W, Fruhwald F, Lassner D, Olschewski A, Olschewski H, Hassoun PM, Kwapiszewska G.

Am J Respir Crit Care Med. 2019 Jun 15;199(12):1550-1560. doi: 10.1164/rccm.201809-1737OC.

PMID:
30557518
11.

Clinical trial design and new therapies for pulmonary arterial hypertension.

Sitbon O, Gomberg-Maitland M, Granton J, Lewis MI, Mathai SC, Rainisio M, Stockbridge NL, Wilkins MR, Zamanian RT, Rubin LJ.

Eur Respir J. 2019 Jan 24;53(1). pii: 1801908. doi: 10.1183/13993003.01908-2018. Print 2019 Jan.

12.

Discordance between Imaging Modalities in the Evaluation of Chronic Thromboembolic Pulmonary Hypertension: A Combined Experience from Two Academic Medical Centers.

Furfaro D, Azadi J, Housten T, Kolb TM, Damico RL, Hassoun PM, Chin K, Mathai SC.

Ann Am Thorac Soc. 2019 Feb;16(2):277-280. doi: 10.1513/AnnalsATS.201809-588RL. No abstract available.

13.

Risk assessment in scleroderma patients with newly diagnosed pulmonary arterial hypertension: application of the ESC/ERS risk prediction model.

Mercurio V, Diab N, Peloquin G, Housten-Harris T, Damico R, Kolb TM, Mathai SC, Hassoun PM.

Eur Respir J. 2018 Oct 18;52(4). pii: 1800497. doi: 10.1183/13993003.00497-2018. Print 2018 Oct. No abstract available.

PMID:
30262575
14.

Assessment of Right Ventricular Function in the Research Setting: Knowledge Gaps and Pathways Forward. An Official American Thoracic Society Research Statement.

Lahm T, Douglas IS, Archer SL, Bogaard HJ, Chesler NC, Haddad F, Hemnes AR, Kawut SM, Kline JA, Kolb TM, Mathai SC, Mercier O, Michelakis ED, Naeije R, Tuder RM, Ventetuolo CE, Vieillard-Baron A, Voelkel NF, Vonk-Noordegraaf A, Hassoun PM; American Thoracic Society Assembly on Pulmonary Circulation.

Am J Respir Crit Care Med. 2018 Aug 15;198(4):e15-e43. doi: 10.1164/rccm.201806-1160ST.

15.

Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosis.

Launay D, Montani D, Hassoun PM, Cottin V, Le Pavec J, Clerson P, Sitbon O, Jaïs X, Savale L, Weatherald J, Sobanski V, Mathai SC, Shafiq M, Cordier JF, Hachulla E, Simonneau G, Humbert M.

PLoS One. 2018 May 15;13(5):e0197112. doi: 10.1371/journal.pone.0197112. eCollection 2018.

16.

Breathing (and Coding?) a Bit Easier: Changes to International Classification of Disease Coding for Pulmonary Hypertension.

Mathai SC, Mathew S.

Chest. 2018 Jul;154(1):207-218. doi: 10.1016/j.chest.2018.04.004. Epub 2018 Apr 21. Review.

PMID:
29684313
17.

Pulmonary Effective Arterial Elastance as a Measure of Right Ventricular Afterload and Its Prognostic Value in Pulmonary Hypertension Due to Left Heart Disease.

Tampakakis E, Shah SJ, Borlaug BA, Leary PJ, Patel HH, Miller WL, Kelemen BW, Houston BA, Kolb TM, Damico R, Mathai SC, Kasper EK, Hassoun PM, Kass DA, Tedford RJ.

Circ Heart Fail. 2018 Apr;11(4):e004436. doi: 10.1161/CIRCHEARTFAILURE.117.004436.

18.

Mycophenolate Mofetil in a Lupus Patient with Pulmonary Hypertension.

Machireddy K, Myint Z, Dein E, Mathai SC, Seo P, Haque U, Manno R, Timlin H.

Cureus. 2018 Jan 29;10(1):e2121. doi: 10.7759/cureus.2121.

19.

Pulmonary arterial hypertension and atrial arrhythmias: incidence, risk factors, and clinical impact.

Mercurio V, Peloquin G, Bourji KI, Diab N, Sato T, Enobun B, Housten-Harris T, Damico R, Kolb TM, Mathai SC, Tedford RJ, Tocchetti CG, Hassoun PM.

Pulm Circ. 2018 Apr-Jun;8(2):2045894018769874. doi: 10.1177/2045894018769874. Epub 2018 Mar 26.

20.

Focused Review of Perioperative Care of Patients with Pulmonary Hypertension and Proposal of a Perioperative Pathway.

Steppan J, Diaz-Rodriguez N, Barodka VM, Nyhan D, Pullins E, Housten T, Damico RL, Mathai SC, Hassoun PM, Berkowitz DE, Maxwell BG, Kolb TM.

Cureus. 2018 Jan 15;10(1):e2072. doi: 10.7759/cureus.2072. Review.

21.

Precision medicine in pulmonary hypertension: Start with the end (point).

Mathai SC.

Int J Cardiol. 2018 Apr 15;257:339-340. doi: 10.1016/j.ijcard.2018.01.033. No abstract available.

PMID:
29506725
22.

The Growing Burden of Pulmonary Hypertension in the Modern Era: A Zebra No More?

Mathai SC, Ryan JJ.

Circ Cardiovasc Qual Outcomes. 2018 Feb;11(2):e004536. doi: 10.1161/CIRCOUTCOMES.118.004536. No abstract available.

PMID:
29444928
23.

Challenges in Pulmonary Hypertension: Controversies in Treating the Tip of the Iceberg. A Joint National Institutes of Health Clinical Center and Pulmonary Hypertension Association Symposium Report.

Elinoff JM, Agarwal R, Barnett CF, Benza RL, Cuttica MJ, Gharib AM, Gray MP, Hassoun PM, Hemnes AR, Humbert M, Kolb TM, Lahm T, Leopold JA, Mathai SC, McLaughlin VV, Preston IR, Rosenzweig EB, Shlobin OA, Steen VD, Zamanian RT, Solomon MA.

Am J Respir Crit Care Med. 2018 Jul 15;198(2):166-174. doi: 10.1164/rccm.201710-2093PP. No abstract available.

24.

Right Ventricular Myofilament Functional Differences in Humans With Systemic Sclerosis-Associated Versus Idiopathic Pulmonary Arterial Hypertension.

Hsu S, Kokkonen-Simon KM, Kirk JA, Kolb TM, Damico RL, Mathai SC, Mukherjee M, Shah AA, Wigley FM, Margulies KB, Hassoun PM, Halushka MK, Tedford RJ, Kass DA.

Circulation. 2018 May 29;137(22):2360-2370. doi: 10.1161/CIRCULATIONAHA.117.033147. Epub 2018 Jan 19.

25.

The impact of ambrisentan and tadalafil upfront combination therapy on cardiac function in scleroderma associated pulmonary arterial hypertension patients: cardiac magnetic resonance feature tracking study.

Sato T, Ambale-Venkatesh B, Lima JAC, Zimmerman SL, Tedford RJ, Fujii T, Hulme OL, Pullins EH, Corona-Villalobos CP, Zamanian RT, Minai OA, Girgis RE, Chin K, Khair R, Damico RL, Kolb TM, Mathai SC, Hassoun PM.

Pulm Circ. 2018 Jan-Mar;8(1):2045893217748307. doi: 10.1177/2045893217748307. Epub 2017 Dec 18.

26.

Right ventricular longitudinal strain is diminished in systemic sclerosis compared with idiopathic pulmonary arterial hypertension.

Mukherjee M, Mercurio V, Tedford RJ, Shah AA, Hsu S, Mullin CJ, Sato T, Damico R, Kolb TM, Mathai SC, Hassoun PM.

Eur Respir J. 2017 Nov 22;50(5). pii: 1701436. doi: 10.1183/13993003.01436-2017. Print 2017 Nov. No abstract available.

27.

PVDOMICS: A Multi-Center Study to Improve Understanding of Pulmonary Vascular Disease Through Phenomics.

Hemnes AR, Beck GJ, Newman JH, Abidov A, Aldred MA, Barnard J, Berman Rosenzweig E, Borlaug BA, Chung WK, Comhair SAA, Erzurum SC, Frantz RP, Gray MP, Grunig G, Hassoun PM, Hill NS, Horn EM, Hu B, Lempel JK, Maron BA, Mathai SC, Olman MA, Rischard FP, Systrom DM, Tang WHW, Waxman AB, Xiao L, Yuan JX, Leopold JA; PVDOMICS Study Group.

Circ Res. 2017 Oct 27;121(10):1136-1139. doi: 10.1161/CIRCRESAHA.117.311737. No abstract available.

28.

Evaluation of criteria for exercise-induced pulmonary hypertension in patients with resting pulmonary hypertension.

Mullin CJ, Hsu S, Amancherla K, Wand A, Rhodes P, Leary PJ, Mukherjee M, Damico RL, Kolb TM, Mathai SC, Hassoun PM, Tedford RJ.

Eur Respir J. 2017 Sep 20;50(3). pii: 1700784. doi: 10.1183/13993003.00784-2017. Print 2017 Sep. No abstract available.

29.

New insights into the recognition, classification and management of systemic sclerosis-associated pulmonary hypertension.

Mullin CJ, Mathai SC.

Curr Opin Rheumatol. 2017 Nov;29(6):561-567. doi: 10.1097/BOR.0000000000000440. Review.

PMID:
28817465
30.

The authors reply.

Metkus TS, Mathai SC, Tedford RJ.

Crit Care Med. 2017 Aug;45(8):e874-e875. doi: 10.1097/CCM.0000000000002505. No abstract available.

31.

Magnetic Resonance Imaging in Pulmonary Arterial Hypertension. Panacea or Pixelation?

Mathai SC, Kawut SM.

Am J Respir Crit Care Med. 2017 Jul 15;196(2):129-131. doi: 10.1164/rccm.201704-0721ED. No abstract available.

PMID:
28707971
32.

Use of thermodilution cardiac output overestimates diagnoses of exercise-induced pulmonary hypertension.

Hsu S, Brusca SB, Rhodes PS, Kolb TM, Mathai SC, Tedford RJ.

Pulm Circ. 2017 Jan 1;7(1):253-255. doi: 10.1086/690629. eCollection 2017 Mar.

33.

Improvement in Right Ventricular Strain with Ambrisentan and Tadalafil Upfront Therapy in Scleroderma-associated Pulmonary Arterial Hypertension.

Mercurio V, Mukherjee M, Tedford RJ, Zamanian RT, Khair RM, Sato T, Minai OA, Torres F, Girgis RE, Chin K, Damico R, Kolb TM, Mathai SC, Hassoun PM.

Am J Respir Crit Care Med. 2018 Feb 1;197(3):388-391. doi: 10.1164/rccm.201704-0789LE. No abstract available.

34.

Poor survival in patients with scleroderma and pulmonary hypertension due to heart failure with preserved ejection fraction.

Bourji KI, Kelemen BW, Mathai SC, Damico RL, Kolb TM, Mercurio V, Cozzi F, Tedford RJ, Hassoun PM.

Pulm Circ. 2017 Apr-Jun;7(2):409-420. doi: 10.1177/2045893217700438. Epub 2017 Mar 27.

35.

Follow-up tricuspid annular plane systolic excursion predicts survival in pulmonary arterial hypertension.

Mazurek JA, Vaidya A, Mathai SC, Roberts JD, Forfia PR.

Pulm Circ. 2017 Apr-Jun;7(2):361-371. doi: 10.1177/2045893217694175. Epub 2017 Mar 13.

36.

Enhancing Insights into Pulmonary Vascular Disease through a Precision Medicine Approach. A Joint NHLBI-Cardiovascular Medical Research and Education Fund Workshop Report.

Newman JH, Rich S, Abman SH, Alexander JH, Barnard J, Beck GJ, Benza RL, Bull TM, Chan SY, Chun HJ, Doogan D, Dupuis J, Erzurum SC, Frantz RP, Geraci M, Gillies H, Gladwin M, Gray MP, Hemnes AR, Herbst RS, Hernandez AF, Hill NS, Horn EM, Hunter K, Jing ZC, Johns R, Kaul S, Kawut SM, Lahm T, Leopold JA, Lewis GD, Mathai SC, McLaughlin VV, Michelakis ED, Nathan SD, Nichols W, Page G, Rabinovitch M, Rich J, Rischard F, Rounds S, Shah SJ, Tapson VF, Lowy N, Stockbridge N, Weinmann G, Xiao L.

Am J Respir Crit Care Med. 2017 Jun 15;195(12):1661-1670. doi: 10.1164/rccm.201701-0150WS.

37.

Exhaled nitric oxide in pulmonary arterial hypertension associated with systemic sclerosis.

Cao Z, Mathai SC, Hummers LK, Shah AA, Wigley FM, Lechtzin N, Hassoun PM, Girgis RE.

Pulm Circ. 2016 Dec;6(4):545-550. doi: 10.1086/688768.

38.

A Review of Clinical Trial Endpoints of Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension and How They Relate to Patient Outcomes in the United States.

Divers C, Platt D, Wang E, Lin J, Lingohr-Smith M, Mathai SC.

J Manag Care Spec Pharm. 2017 Jan;23(1):92-104. doi: 10.18553/jmcp.2017.23.1.92. Review.

39.

Pulmonary Arterial Compliance in Acute Respiratory Distress Syndrome: Clinical Determinants and Association With Outcome From the Fluid and Catheter Treatment Trial Cohort.

Metkus TS, Tampakakis E, Mullin CJ, Houston BA, Kolb TM, Mathai SC, Damico R, Maron BA, Hassoun PM, Brower RG, Tedford RJ.

Crit Care Med. 2017 Mar;45(3):422-429. doi: 10.1097/CCM.0000000000002186.

40.

Rationale and study design of MOTION: A phase 4, prospective, single-arm, open-label study to measure outcomes in patients with pulmonary arterial hypertension not on active treatment.

Mathai SC, Minai O, Sullivan SD, Lerner D, Levine D.

Respir Med. 2017 Jan;122 Suppl 1:S23-S27. doi: 10.1016/j.rmed.2016.11.002. Epub 2016 Nov 2.

41.

Heart Rate Dependence of the Pulmonary Resistance x Compliance (RC) Time and Impact on Right Ventricular Load.

Metkus TS, Mullin CJ, Grandin EW, Rame JE, Tampakakis E, Hsu S, Kolb TM, Damico R, Hassoun PM, Kass DA, Mathai SC, Tedford RJ.

PLoS One. 2016 Nov 18;11(11):e0166463. doi: 10.1371/journal.pone.0166463. eCollection 2016.

42.

Beast of Pulmonary Arterial Hypertension Burden.

Mathai SC, McLaughlin VV.

JAMA Cardiol. 2016 Dec 1;1(9):1030-1031. doi: 10.1001/jamacardio.2016.3829. No abstract available.

PMID:
27851836
43.

An observational study of inhaled-treprostinil respiratory-related safety in patients with pulmonary arterial hypertension.

Zamanian RT, Levine DJ, Bourge RC, De Souza SA, Rosenzweig EB, Alnuaimat H, Burger C, Mathai SC, Leedom N, DeAngelis K, Lim A, De Marco T.

Pulm Circ. 2016 Sep;6(3):329-37. doi: 10.1086/688059.

44.

Lung Transplantation in Scleroderma. Time for the Pendulum to Swing?

Eberlein M, Mathai SC.

Ann Am Thorac Soc. 2016 Jun;13(6):767-9. doi: 10.1513/AnnalsATS.201512-801ED. No abstract available.

PMID:
27295149
45.

Right Ventricular Functional Reserve in Pulmonary Arterial Hypertension.

Hsu S, Houston BA, Tampakakis E, Bacher AC, Rhodes PS, Mathai SC, Damico RL, Kolb TM, Hummers LK, Shah AA, McMahan Z, Corona-Villalobos CP, Zimmerman SL, Wigley FM, Hassoun PM, Kass DA, Tedford RJ.

Circulation. 2016 Jun 14;133(24):2413-22. doi: 10.1161/CIRCULATIONAHA.116.022082. Epub 2016 May 11.

46.

Quality of life in patients with chronic thromboembolic pulmonary hypertension.

Mathai SC, Ghofrani HA, Mayer E, Pepke-Zaba J, Nikkho S, Simonneau G.

Eur Respir J. 2016 Aug;48(2):526-37. doi: 10.1183/13993003.01626-2015. Epub 2016 Apr 13. Review.

47.

The Minimal Important Difference in Borg Dyspnea Score in Pulmonary Arterial Hypertension.

Khair RM, Nwaneri C, Damico RL, Kolb T, Hassoun PM, Mathai SC.

Ann Am Thorac Soc. 2016 Jun;13(6):842-9. doi: 10.1513/AnnalsATS.201512-824OC.

48.

Management of interstitial lung disease associated with connective tissue disease.

Mathai SC, Danoff SK.

BMJ. 2016 Feb 24;352:h6819. doi: 10.1136/bmj.h6819. Review.

49.

Can a simple test of functional capacity add to the clinical assessment of diabetes?

Stewart T, Caffrey DG, Gilman RH, Mathai SC, Lerner A, Hernandez A, Pinto ME, Huaylinos Y, Cabrera L, Wise RA, Miranda JJ, Checkley W.

Diabet Med. 2016 Aug;33(8):1133-9. doi: 10.1111/dme.13032. Epub 2015 Dec 29.

50.

Prognostic Significance of Biomarkers in Pulmonary Arterial Hypertension.

Al-Naamani N, Palevsky HI, Lederer DJ, Horn EM, Mathai SC, Roberts KE, Tracy RP, Hassoun PM, Girgis RE, Shimbo D, Post WS, Kawut SM; ASA-STAT Study Group.

Ann Am Thorac Soc. 2016 Jan;13(1):25-30. doi: 10.1513/AnnalsATS.201508-543OC.

Supplemental Content

Loading ...
Support Center